drugset / Trial / NCT03582722
Weight Loss Aid in an Exposed Population
Phase 4
Completed
100 enrolled
Emory University
Healthway Compounding Pharmacy · collabMichigan Public Health Departments · collabNational Institute of Environmental Health Sciences (NIEHS) · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
This study will explore whether the use of orlistat results in weight loss that is accompanied by a reduction in the body burdens of polybrominated biphenyls (PBB) and other Persistent Organic Pollutants (POPs).
Timeline
- Start
- 2018-09-14
- Primary completion
- 2022-06-30
- Completion
- 2022-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orlistat | Small molecule | 60 mg | — |